OBJECTIVE: This online survey aims to compare the side effects that may occur after inactivated severe acute respiratory syndrome coronavirus 2 (COVID-19) vaccination by age groups. METHODS: A total of 411 participants aged 18-100 who received inactivated coronavirus disease 2019 vaccine were included in the study. RESULTS: Participants were divided into four groups according to their ages (i.e., 20-35, 36-50, 51-65, and over 65 years old). Vaccine-related side effects were primarily seen in the 20-35 age group and at least in the >65 age group (p<0.001). The most common side effects were pain, redness, swelling, and numbness at the injection site. Fatigue and headache were other common side effects. After vaccination, 3 (0.73%) participants had hypertension, and 1 (0.24%) had an asthma attack and was admitted to the hospital. No severe side effects were observed in any of the patients. The most critical factors determining the development of side effects were female gender and young age. CONCLUSION: According to the results of this study, different types and rates of side effects are seen in all age groups after the inactivated coronavirus disease 2019 vaccine. Since the 20-35 age group and female gender are at risk of side effects, it would be more appropriate to follow up the side effects after vaccination according to gender and age.
Aim: In this study, it was aimed to investigate and compare the effects of menstrual cycle phases on preoperative anxiety and postoperative pain scores in patients given midazolam for premedication before anesthesia. Methods: Septorhinoplasty, goiter surgery and laparoscopic cholecystectomy 126 female patients, aged 21-45, with American Society of Anesthesiologists (ASA) score I-II and with regular menstrual cycles, were included. Of the cases; The phase of the menstrual cycle was recorded according to the last menstrual period (SAT) and accordingly the patients were divided into 3 groups as Follicular phase, the Ovulatory phase, and the Luteal phase. Anxiety assessment was performed using the State-Trait Anxiety Inventory (STAI FORM TX-1) test. Anxiety scores were evaluated by performing a preoperative test 3 minutes before and 1 hour after intravenous (IV) administration of 0.02 mg/kg midazolam. Visual analog scale (VAS) was used for postoperative pain assessment. Results: Midazolam was found to decrease STAI FORM TX-1 scores the most during the ovulatory phase of the menstrual cycle, but there was no significant difference between the groups in terms of VAS scores. Conclusion: It has been observed that premedication with midazolam reduces preoperative anxiety in all phases of the menstrual cycle in women of reproductive age, but is most effective in the ovulatory phase. The effect of premedication with midazolam on postoperative pain does not change according to the phases of the menstrual cycle.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.